Argent Trust Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9M | Buy |
86,362
+2,464
| +3% | +$325K | 0.32% | 77 |
|
|
2026
Q1 | $11.7M | Sell |
83,898
-3,217
| -4% | -$450K | 0.4% | 59 |
|
|
2025
Q4 | $10.7M | Sell |
87,115
-2,332
| -3% | -$283K | 0.37% | 64 |
|
|
2025
Q3 | $9.93M | Buy |
89,447
+21,785
| +32% | +$2.48M | 0.35% | 70 |
|
|
2025
Q2 | $7.5M | Sell |
67,662
-1,055
| -2% | -$112K | 0.28% | 75 |
|
|
2025
Q1 | $7.7M | Buy |
68,717
+904
| +1% | +$93.3K | 0.32% | 70 |
|
|
2024
Q4 | $6.26M | Sell |
67,813
-1,114
| -2% | -$100K | 0.26% | 85 |
|
|
2024
Q3 | $5.78M | Sell |
68,927
-5,147
| -7% | -$393K | 0.24% | 87 |
|
|
2024
Q2 | $5.08M | Sell |
74,074
-3,704
| -5% | -$247K | 0.22% | 95 |
|
|
2024
Q1 | $5.7M | Sell |
77,778
-922
| -1% | -$70.9K | 0.26% | 87 |
|
|
2023
Q4 | $6.38M | Sell |
78,700
-16,460
| -17% | -$1.28M | 0.32% | 71 |
|
|
2023
Q3 | $7.13M | Buy |
95,160
+5,820
| +7% | +$448K | 0.39% | 64 |
|
|
2023
Q2 | $6.89M | Buy |
89,340
+6,866
| +8% | +$548K | 0.37% | 61 |
|
|
2023
Q1 | $6.84M | Sell |
82,474
-4,983
| -6% | -$413K | 0.43% | 61 |
|
|
2022
Q4 | $7.51M | Sell |
87,457
-40
| -0% | -$3.17K | 0.5% | 51 |
|
|
2022
Q3 | $5.4M | Buy |
87,497
+2,313
| +3% | +$146K | 0.39% | 69 |
|
|
2022
Q2 | $5.26M | Buy |
85,184
+6,911
| +9% | +$428K | 0.36% | 72 |
|
|
2022
Q1 | $4.65M | Buy |
78,273
+5,316
| +7% | +$340K | 0.28% | 81 |
|
|
2021
Q4 | $5.3M | Buy |
72,957
+506
| +0.7% | +$34.9K | 0.31% | 74 |
|
|
2021
Q3 | $5.06M | Sell |
72,451
-3,289
| -4% | -$231K | 0.33% | 70 |
|
|
2021
Q2 | $5.21M | Sell |
75,740
-2,321
| -3% | -$155K | 0.34% | 69 |
|
|
2021
Q1 | $5.04M | Buy |
78,061
+16,093
| +26% | +$1.04M | 0.35% | 66 |
|
|
2020
Q4 | $3.61M | Sell |
61,968
-145
| -0.2% | -$8.75K | 0.28% | 84 |
|
|
2020
Q3 | $3.92M | Buy |
62,113
+14,290
| +30% | +$991K | 0.35% | 69 |
|
|
2020
Q2 | $3.68M | Sell |
47,823
-10,401
| -18% | -$797K | 0.34% | 67 |
|
|
2020
Q1 | $4.35M | Buy |
58,224
+3,844
| +7% | +$266K | 0.49% | 55 |
|
|
2019
Q4 | $3.53M | Buy |
54,380
+561
| +1% | +$36.5K | 0.31% | 79 |
|
|
2019
Q3 | $3.41M | Buy |
53,819
+11,272
| +26% | +$737K | 0.33% | 75 |
|
|
2019
Q2 | $2.87M | Buy |
42,547
+1,008
| +2% | +$66.3K | 0.29% | 85 |
|
|
2019
Q1 | $2.7M | Sell |
41,539
-241
| -0.6% | -$16K | 0.28% | 89 |
|
|
2018
Q4 | $2.61M | Sell |
41,780
-1,411
| -3% | -$98.6K | 0.31% | 84 |
|
|
2018
Q3 | $3.29M | Sell |
43,191
-1,019
| -2% | -$77K | 0.38% | 70 |
|
|
2018
Q2 | $3.13M | Buy |
44,210
+35,215
| +391% | +$2.49M | 0.38% | 68 |
|
|
2018
Q1 | $678K | Sell |
8,995
-1,073
| -11% | -$85.3K | 0.19% | 122 |
|
|
2017
Q4 | $722K | Sell |
10,068
-804
| -7% | -$61.1K | 0.28% | 110 |
|
|
2017
Q3 | $881K | Sell |
10,872
-52
| -0.5% | -$3.98K | 0.35% | 81 |
|
|
2017
Q2 | $774K | Sell |
10,924
-2,720
| -20% | -$181K | 0.32% | 96 |
|
|
2017
Q1 | $927K | Sell |
13,644
-1,710
| -11% | -$120K | 0.38% | 79 |
|
|
2016
Q4 | $1.1M | Sell |
15,354
-2,089
| -12% | -$155K | 0.49% | 57 |
|
|
2016
Q3 | $1.38M | Sell |
17,443
-2,636
| -13% | -$214K | 0.59% | 46 |
|
|
2016
Q2 | $1.68M | Buy |
20,079
+2,419
| +14% | +$215K | 0.74% | 33 |
|
|
2016
Q1 | $1.62M | Buy |
17,660
+694
| +4% | +$62.6K | 0.79% | 36 |
|
|
2015
Q4 | $1.72M | Buy |
16,966
+951
| +6% | +$99K | 0.85% | 28 |
|
|
2015
Q3 | $1.57M | Buy |
16,015
+227
| +1% | +$25.2K | 0.89% | 22 |
|
|
2015
Q2 | $1.85M | Sell |
15,788
-10
| -0.1% | -$1.09K | 0.93% | 22 |
|
|
2015
Q1 | $1.55M | Buy |
15,798
+396
| +3% | +$40.2K | 0.78% | 32 |
|
|
2014
Q4 | $1.45M | Buy |
+15,402
| New | +$1.59M | 0.87% | 28 |
|
Other funds holding GILD
Argent Trust Co's GILD Position: Q2 2026 in Review
Argent Trust Co increased its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, buying an estimated $325K and bringing the position to 86,362 shares worth $10.9M. The position accounts for 0.32% of the portfolio, ranked #77.
Argent Trust Co first reported a position in GILD in Q4 2014 and has held it in 47 quarters since. The position peaked at $11.7M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Argent Trust Co held 86,362 shares of Gilead Sciences worth $10.9M as of Q2 2026.
- Argent Trust Co bought 2,464 Gilead Sciences shares in Q2 2026, an estimated $325K.
- Gilead Sciences made up 0.32% of Argent Trust Co's portfolio in Q2 2026, its #77 holding.
- Argent Trust Co first reported a position in Gilead Sciences in Q4 2014 and has held it in 47 quarters since.
- Argent Trust Co's Gilead Sciences position peaked at $11.7M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.